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Abstract Whether nucleoside diphosphate kinase (NDPK) is
involved in neuronal differentiation was investigated with special
reference to its enzyme activity. Neurite outgrowth of PC12D
cells induced by nerve growth factor or a cyclic AMP analog was
suppressed to some extent when inactive NDPKs (the active site
histidine 118 was replaced with alanine), not active forms, were
transiently overexpressed. This suppression was more definite in
their stably expressed clones. NDPKL-transfected clones and, to
a lesser extent, NDPKK-transfected clones, but not inactive
NDPK-transfected clones, extended neurites without differentia-
tion inducers. These results imply that NDPKs may play a role
by exerting their enzyme activity during differentiation of PC12
cells.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
Nucleoside diphosphate kinase (NDPK, EC 2.7.4.6) is a
ubiquitous enzyme catalyzing a transfer of the terminal phos-
phate from nucleoside triphosphates ((d)NTPs) to nucleoside
diphosphates ((d)NDPs) by forming a high energy phospho-
rylated enzyme intermediate [1]. NDPK plays a key role in
maintaining intracellular pools of (d)NTPs utilized for synthe-
ses of cellular compounds such as nucleic acids, proteins, pol-
ysaccharides and lipids. Also, this enzyme is suggested to play
roles as a GTP-supplying machinery in the vicinity of hetero-
trimeric GTP-binding proteins in signal transduction [2] and
tubulins in microtubule polymerization [3].
In recent years, it has been suggested that NDPK may have
multi-functions as shown by its identity to nm23 [4^7], Awd
[8,9], Puf [10,11] and I-factor [12,13]. NDPK enzyme activity
is not required for the latter two functions [11,13]. Whether
NDPK/nm23 requires the enzyme activity for suppression of
metastasis still remains ambiguous. Since NDPK is presumed
to be involved in the regulation of wide variety of cellular
functions, including cell proliferation [14,15], di¡erentiation
[16^18], development [9,19] and apoptosis [16], it is essential
to know whether its enzyme activity is required for each of
these cases for total understanding of NDPK in the cell. In
the present study, we investigated the possible role of NDPK
in the neuronal di¡erentiation of PC12D cells, a sub-cell line
of rat pheochromocytoma PC12 cells, which can be induced
to di¡erentiate very quickly by stimulation of nerve growth
factor (NGF) or elevation of intracellular cyclic AMP
(cAMP) levels [20]. When PC12D cells were transfected with
expression vectors harboring cDNAs of hemagglutinin (HA)-
tagged active NDPK isoforms and their mutant NDPKs de-
fective in their enzyme activity, those cell clones transfected
with inactive NDPKs showed reduced neurite outgrowth in
response to NGF or dibutyryl cAMP (dbcAMP). Further-
more, active NDPK-transfected clones, not inactive NDPK-
transfected clones, became capable of extending neurites with
no stimulation by di¡erentiation inducers. Therefore, the en-
zyme activity of NDPK was found to be crucial for the neu-
rite outgrowth of PC12D cells.
2. Materials and methods
2.1. Materials
PC12D cells were kindly provided by Dr. M. Sano (Institute for
Developmental Research, Aichi Human Service Center). Monoclonal
antibodies for rat NDPK isoforms were previously described [7,21].
An anti-HA mouse monoclonal antibody was kindly donated from
Dr. N. Hanai (Tokyo Research Laboratories, Kyowa Hakko Kogyo
Co.). All other materials were obtained from commercial sources,
unless described otherwise.
2.2. Construction of expression vectors
The cDNAs coding for active NDPK and their mutant proteins in
which the active site histidine 118 in rat NDPKs was replaced with
alanine (NDPKKH118A and NDPKLH118A), were constructed using
PCR-based technique from the pBluescript KS(+) plasmid harboring
NDPKK or NDPKL cDNA cloned previously [22,23]. In another set
of cDNAs the sequence coding for the HA epitope YPYDVPDYA
was inserted in frame between alanine 2 and asparagine 3 by PCR
using primers containing HA sequence. These cDNAs were inserted in
EcoRI site of the pBluescriptII SK(+) plasmid (Stratagene). These
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cDNAs were subcloned in pET-17b vector (Novagen) for production
of recombinant NDPKs in E. coli and in pcDNA3.1(+) vector (Invi-
trogen) for expression in PC12D cells. The sequence of all constructs
was con¢rmed using a Thermo Sequenase £uorescent labelled primer
cycle sequencing kit (Amersham) and an automated DNA sequencing
system (Shimazu, model 1000L).
2.3. Expression and puri¢cation of recombinant NDPKs
E. coli BL21 (DE3) pLysS competent cells were transformed with
the pET-17b vectors harboring active and inactive NDPK cDNAs.
The bacterial culture was grown at 37‡C and the expression was
induced by the addition of 1 mM IPTG. After centrifugation the
resulting cell pellet was suspended in a lysis bu¡er (20 mM Tris-
HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 0.1% Triton X-100,
0.1 mM PMSF) and treated with freezing and thawing, followed by
sonication on ice until it lost viscosity. The recombinant NDPKs were
recovered from high-speed supernatant fraction and puri¢ed to almost
homogeneity by one-step a⁄nity chromatography using an ATP-
Sepharose column as previously described [24].
2.4. Assay of NDPK activity
NDPK activity was measured by the pyruvate kinase-lactate dehy-
drogenase coupled enzyme reaction essentially as described previously
[25]. Protein concentration was measured using a BCA Protein Assay
Kit (Pearce) with BSA as a standard.
2.5. Cell culture
PC12D cells were cultured at 37‡C under a humidi¢ed 5% CO2
atmosphere in a growth medium, Dulbecco’s modi¢ed Eagle medium
(DMEM) with 4.5 g/l glucose supplemented with 10% horse serum
and 5% fetal calf serum in non-coated tissue culture dishes until 60^
70% con£uence. The cells were passaged by incubating for 10 min
with 1 mM EDTA in Dulbecco’s phosphate-bu¡ered saline (PBS).
2.6. Transient transfection and immunostaining
PC12D cells were transfected with pcDNA3.1(+) vectors harboring
HA-NDPK cDNAs by lipofection using a Lipofect AMINE PLUS
Reagent (Gibco BRL) according to the manufacturer’s instructions.
After 24 h, the cells were transferred to a chamber slide (Nunc) coated
with poly-L-lysine at a density of 1.0U104 cells/cm2 and cultured for
another 24 h. For analyses of neurite outgrowth, the medium was
replaced with the fresh one containing 50 ng/ml NGF (Takara) or
1 mM dbcAMP (Sigma) and the cells were cultured further for 48 h.
The cells were ¢xed with 4% paraformaldehyde in PBS at room tem-
perature for 20 min, washed with PBS and permeabilized with 0.1%
Triton X-100 in PBS for 3 min. After blocking with 1% BSA in PBS
at room temperature, samples were treated with an anti-HA mouse
monoclonal antibody in PBS containing 1% BSA at 4‡C overnight,
followed by incubation with a second antibody, £uorescein isothio-
cyanate (FITC)-conjugated anti-mouse IgG antibody in PBS contain-
ing 1% BSA at room temperature for 1 h. For quanti¢cation of
neurite outgrowth, the cells expressing exogenous HA-NDPK were
identi¢ed (at least more than 150, up to 300, in number) and those
forming neurites longer than 2- or 5-fold the diameter of the cell body
were counted.
2.7. Stable transfection
Stable transfection was performed by electroporation as follows.
Cells (4.0U106) in 0.4 ml of PBS with 15 Wg of pcDNA3.1(+) vector
harboring HA-NDPK cDNAs were treated using a Bio-Rad gene
pulser (setting: 0.3 kV, 250 microfarad) as described [7]. Selection
was done with the growth medium containing 0.7 mg/ml G418 for
3 weeks. G418-resistant colonies were isolated using the cloning cyl-
inders and expanded in the growth medium containing 0.5 mg/ml
G418. Two clones of each group showing the highest expression
were selected by Western blotting with an anti-HA antibody. Control
clones transfected with the vector alone were selected randomly from
those that integrated the vector into their chromosomal DNA. The
selected clones were plated on poly-L-lysine-coated dishes at a density
of 1.0U104 cells/cm2 for di¡erentiation experiments. After 24 h, me-
dium was replaced with the fresh one containing 50 ng/ml NGF or
1 mM dbcAMP. The morphological change was observed every
day, and the relative ratio of cells forming neurites longer than
2-fold the diameter of the cell body out of total cells counted under
a phase-contrast microscope (from 120 to 330 in number) was calcu-
lated.
3. Results
3.1. Puri¢cation and enzyme activity of recombinant NDPKs
For the purpose of examining whether the replacement of
amino acid in the active site and the insertion of HA epitope
tag in£uence the NDPK enzyme activity, we prepared re-
combinant proteins using each cDNA, puri¢ed them and ex-
amined their enzyme activity (Fig. 1). The recombinant
NDPKs expressed in E. coli were puri¢ed to almost homo-
geneity by one-step a⁄nity chromatography on the ATP-
Sepharose column. The HA-tagged NDPKs were shown to
have larger molecular mass than NDPKs without HA epitope
tag by SDS-PAGE. When the enzyme activity was measured
by the enzyme-coupled assay method, the replacement of the
active site histidine 118 with alanine (NDPKKH118A and
NDPKLH118A) resulted in the loss of enzyme activity. On the
other hand, there was no di¡erence in the speci¢c activity
between NDPKs with and without HA epitope tag. From
these results we concluded that HA-NDPK cDNAs and their
protein products can be used for further experiments to dis-
FEBS 21587 22-2-99
Fig. 1. Puri¢cation and enzyme activity of recombinant NDPKs.
The recombinant NDPKs expressed in E. coli were puri¢ed by one-
step a⁄nity chromatography on an ATP-Sepharose column. A: The
E. coli lysates and puri¢ed NDPKs were subjected to SDS-PAGE,
followed by staining with coomassie brilliant blue. Lanes 1 and 9,
NDPKK ; lanes 2 and 10, NDPKL ; lanes 3 and 11, NDPKKH118A ;
lanes 4 and 12, NDPKLH118A ; lanes 5 and 13, HA-NDPKK ; lanes 6
and 14, HA-NDPKL ; lanes 7 and 15, HA-NDPKKH118A ; lanes 8
and 16, HA-NDPKLH118A. Arrow shows the position of recombi-
nant proteins. B: The enzyme activity of the E. coli lysates and pu-
ri¢ed recombinant NDPKs.
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criminate exogenous NDPK from the endogenous NDPK in
the cells.
3.2. Transient expression of NDPKs in PC12D cells
PC12D cells were transfected with the pcDNA3.1(+) vector
containing cDNA of HA-NDPKK, HA-NDPKL, HA-
NDPKKH118A or HA-NDPKLH118A. After 48 h cultivation,
the cells were treated with 50 ng/ml NGF or 1 mM dbcAMP
and incubated for additional 48 h, followed by ¢xation and
staining with an anti-HA antibody. Then, the cells expressing
exogenous HA-NDPK were identi¢ed under a £uorescence
microscope (Fig. 2A), and among those the cells forming neu-
rites longer than 2- or 5-fold the diameter of the cell body
were counted. The control cells treated with vector alone were
examined under a phase-contrast microscope because of the
absence of £uorescence signal. The neurite outgrowth stimu-
lated by NGF or dbcAMP showed a tendency to be sup-
pressed in PC12D cells expressing inactive HA-NDPK (Fig.
2B). This led to the speculation that the enzyme activity of
NDPK may take no small part in neurite outgrowth in
PC12D cells. This was more extensively investigated by stable
transfection experiments as described below.
3.3. Stable expression of NDPKs in PC12D cells
The stable transfectants were prepared as described in Sec-
tion 2 and clones expressing exogenous HA-NDPKs were
selected by Western blotting. Two representative clones se-
lected from each group are shown in Fig. 3. Morphological
di¡erence of these transfectants was examined after 2 days
incubation in the absence and the presence of NGF or
dbcAMP (Fig. 4A). Surprisingly, cell clones expressing HA-
NDPKL were capable of extending neurites without any in-
ducers of di¡erentiation. HA-NDPKK-transfected clones
showed only marginal neurite outgrowth under the condition.
The clones expressing inactive NDPKs were indistinguishable
from the control clones transfected with the vector alone. On
the other hand, when the di¡erentiation of each transfectant
was examined in the presence of NGF or dbcAMP, cell clones
overexpressing HA-NDPKK or HA-NDPKL extended neu-
rites to an extent similar to the control clones. In contrast,
neurite outgrowth of transfectants expressing inactive NDPK,
HA-NDPKKH118A or HA-NDPKLH118A in response to the in-
ducers was remarkably reduced. In this case, inactive forms of
both NDPK isoforms exhibited almost similar potency to in-
hibit the morphological change as shown in Fig. 4B. It is
important to note that NDPK enzyme activity in these cell
extracts was not largely altered by the overexpression of mu-
tant inactive NDPKs (data not shown).
We examined possible relationship between di¡erentiation
potential and proliferative potential in the transfected PC12D
cells. Interestingly, doubling time of these transfectants was
approximately 30 h except HA-NDPKL transfectants in which
doubling time was prolonged to over 40 h.
4. Discussion
The distribution of rat two NDPK isoforms di¡ers from
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Fig. 3. Western blotting of the cell lysates extracted from PC12D
transfectants. The stable transfectants were established as described
in Section 2. Their lysates were subjected to Western blotting with
an anti-NDPK antibody cross-reactive to both isoforms (a), an anti-
NDPKK-speci¢c antibody (b) or an anti-NDPKL-speci¢c antibody
(c), and the expression of exogenous HA-NDPKs was con¢rmed by
their mobility and indicated by large arrows. Endogenous NDPKs
are indicated by small arrows.
Fig. 2. Neurite outgrowth of PC12D cells transiently transfected
with various HA-NDPK cDNAs. A: After 48 h of transfection, the
cells were treated with 50 ng/ml NGF or 1 mM dbcAMP for addi-
tional 48 h to induce neurite outgrowth. Then the cells were ¢xed,
stained with an anti-HA antibody, and the cells expressing exoge-
nous HA-NDPK were identi¢ed under a £uorescence microscope
(right). Phase-contrast photograph is shown on the left side. B: The
percentage of the cells having neurites with length exceeding 2- or
5-fold the diameter of cell body among those expressing HA-NDPK
is shown.
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tissue to tissue [23] ; NDPKK is the major form in most tis-
sues, whereas NDPKL is highly expressed in a limited number
of tissues such as cerebrum and testis. These observations led
us to speculate that NDPKL may play some speci¢c roles in
neuronal cells and to investigate the role of NDPK in neuro-
nal di¡erentiation of PC12 cells. To our surprise was the
¢nding that PC12D cell clones overexpressing NDPKL obvi-
ously became to be capable of extending neurites without any
di¡erentiation inducers and showed decreased proliferative
activity. This e¡ect was dependent on its enzyme activity be-
cause NDPKLH118A of which enzyme activity was nulli¢ed
could not reproduce this phenotypic change. Since overexpres-
sion of NDPKK showed only marginal e¡ect, speci¢c role of
NDPKL in the neuronal di¡erentiation is strongly suggested.
However, the role of NDPK isoforms in the di¡erentiation
processes seems to be more complicated. This is exempli¢ed in
the experiments in which stable transfectants were examined
regarding their response to di¡erentiation inducers, NGF and
dbcAMP. In this case, not only NDPKLH118A but also
NDPKKH118A acted inhibitory for morphological change in-
duced by these reagents. These di¡erences may be partly due
to the possible distinct potencies of NDPK isoforms and/or to
the di¡erential expression levels of exogenous proteins em-
ployed in this study, and remain to be studied further.
It has been believed that NDPKs mostly exist in the cell
cytosol as a soluble free form [1]. However, we previously
revealed membrane-associated form of NDPK [25] and postu-
lated importance of its physical interaction with G protein-
coupled signal transduction systems [26^28]. Some recent lit-
eratures describe another possible target proteins which
NDPK interacts with [29,30]. To extend this idea, it is essen-
tial to demonstrate convincing data that suggest protein-pro-
tein interaction in any NDPK-related phenomena in vivo. In
this respect, it should be emphasized that the overexpression
of mutant inactive NDPKs suppressed NGF- or dbcAMP-
induced neurite outgrowth of PC12D cells, since under these
conditions NDPK enzyme activity in these cell extracts was
not largely a¡ected. Therefore, suppression by these inactive
enzymes is not likely due to the altered NDPK enzyme activ-
ity in the cell but rather to their dominant negative e¡ects. In
other words, it is conceivable that the enzyme activity of en-
dogenous NDPKs is required at a speci¢c site where they
should be for extending neurites. When inactive NDPKs are
present, the endogenous enzymes may be displaced from their
binding site, as a result, leading to incomplete neurite out-
growth of PC12D cells. Recent studies revealed that NGF
signaling is linked to mitogen-activated protein kinase
(MAPK) cascades [31] and that elevation of intracellular
cAMP levels leads to activation of MAPK cascade via acti-
vation of cAMP-dependent protein kinase (PKA) and Rap1, a
member of the Ras superfamily [32] in PC12 cells. Thus, both
di¡erentiation inducers seem to share in part their signaling
pathway. Taking into account the fact that mutant inactive
NDPKs can interfere with both signaling pathways, the inter-
action site of NDPKs may be located in the common part of
these two signaling pathways. On the other hand, it cannot be
ruled out that NDPK may in£uence neurite outgrowth by
altering microtubule dynamics as shown by its colocalization
with microtubules [3,33]. However, whether NDPK has an
ability to in£uence tubulin polymerization has been argued
[34] and remains to be studied further. In PC12 cells over-
expression of NDPK/nm23 increases expression of L-tubulin
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Fig. 4. Neurite outgrowth in stable PC12D transfectants. A: PC12D
cell clones stably transfected with the vector alone (clone #15) (a),
HA-NDPKK (clone # 225) (b), HA-NDPKL (clone #70) (c), HA-
NDPKKH118A (clone #108) (d), or HA-NDPKLH118A (clone #203)
(e). Neurite outgrowth of these PC12D transfectants was examined
after 48 h treatment with or without 50 ng/ml NGF or 1 mM
dbcAMP under a phase-contrast microscope. B: Quanti¢cation of
neurite outgrowth in stable transfectants. Each transfectant was
treated as in A. The relative number (in percentage) of cells having
neurites with length exceeding 2-fold the diameter of cell body is
shown.
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as well as neuro¢lament, but no description is provided for
the interaction between L-tubulin and NDPK/nm23 [35]. Iden-
ti¢cation of the target protein(s) which NDPKs interact with
for the neuronal di¡erentiation of PC12D cells is under cur-
rent investigation.
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